Red-orange crystalline powder, an antibiotic used to treat traveler's diarrhea, irritable bowel syndrome and hepatic encephalopathy.
Fine or granular red powder, an active ingredient used to treat tuberculosis, travelers' diarrhea.
Amorphous red-purple powder, an active ingredient used to treat tuberculosis, Helicobacter pylori and the mycobacterium avium complex.
Red to brownish-red crystalline powder, an active ingredient used to treat tuberculosis.
Dark red to reddish-brown crystalline powder, an antibiotic used to treat tuberculosis.
White crystalline powder and active ingcredient for the treatment of tuberculosis.
White crystalline powder, Widely used in Pharmaceuticals, Nutraceuticals, Health functional foods, Dietary supplements, Skin-Whitening products, Cosmetics etc.
White powder, is the intermediate for synthesis of levetiracetam.
During 16th Dec to 18th Dec, 2020, Luohe Chief Pharma participated in Shanghai CPHI.
We got the Drug Manufacturing License on-site audit from NMPA.
The company was registered and founded in Luohe, Henan
The factory was built in Yancheng District, Luohe City
Enzyme pilot plant was established
Enzyme fermentation plant was built
Enzymatic reaction plant, Enzymatic products refine plant were established
R&D, trial production of Rifamycin Sodium, Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin S were completed
The QC laboratory and QA system began to operate
Synthesis plants of Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium, Rifamycin S were completed
Site audit for Drug Manufacturing License from NMPA
Pilot production of Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium & Rifamycin S was completed
Process Validation for Rifabutin, Rifaximin, Sodium Aminosalicylate, Rifamycin Sodium, and Rifamycin S was started
Submission of USDMFs and CEPs for Rifabutin, Rifaximin, Rifamycin Sodium, Rifamycin S was began
USDMF submission for Rifamycin S was completed
WC for Rifaximin and Rifamycin Sodium were obtained
WC for Rifabutin was obtained
Sep 2013
Mar 2016
Dec 2017
Dec 2018
Oct 2019
Dec 2019
Oct 2020
Dec 2020
Jan 2021
Feb 2021
April 2021
July 2021
Sep-Nov 2021
May 2022
Copyright ? 2021 Luohe Chief Pharmaceutical Co., Ltd 豫ICP備2021017587號-1